Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

SELL
$7.2 - $9.47 $2.39 Million - $3.14 Million
-331,735 Reduced 94.78%
18,265 $138,000
Q1 2023

May 11, 2023

BUY
$8.36 - $11.37 $2.79 Million - $3.8 Million
333,869 Added 2069.74%
350,000 $3.1 Million
Q4 2022

Feb 13, 2023

SELL
$7.95 - $9.48 $73,672 - $87,851
-9,267 Reduced 36.49%
16,131 $147,000
Q3 2022

Nov 10, 2022

BUY
$6.86 - $11.95 $55,566 - $96,795
8,100 Added 46.83%
25,398 $205,000
Q2 2022

Aug 19, 2022

BUY
$7.38 - $10.4 $127,659 - $179,899
17,298 New
17,298 $130,000
Q1 2022

May 13, 2022

SELL
$7.33 - $9.39 $680,392 - $871,607
-92,823 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$7.9 - $10.19 $733,301 - $945,866
92,823 New
92,823 $744,000
Q3 2021

Nov 15, 2021

SELL
$8.38 - $10.18 $441,131 - $535,885
-52,641 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$9.9 - $11.56 $521,145 - $608,529
52,641 New
52,641 $521,000
Q4 2020

Feb 16, 2021

SELL
$8.61 - $11.04 $506,767 - $649,792
-58,858 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$8.57 - $12.69 $504,413 - $746,908
58,858 New
58,858 $530,000
Q2 2020

Aug 14, 2020

SELL
$8.12 - $13.12 $185,655 - $299,975
-22,864 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$6.69 - $13.45 $131,050 - $263,472
-19,589 Reduced 46.14%
22,864 $205,000
Q4 2019

Feb 14, 2020

BUY
$6.53 - $10.72 $145,312 - $238,552
22,253 Added 110.16%
42,453 $416,000
Q3 2019

Nov 14, 2019

BUY
$6.16 - $9.6 $124,432 - $193,920
20,200 New
20,200 $139,000
Q1 2019

May 15, 2019

SELL
$15.58 - $20.01 $2.11 Million - $2.7 Million
-135,144 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$14.59 - $23.84 $1.97 Million - $3.22 Million
135,144 New
135,144 $2.08 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.